| NCT01134614 |
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01134614 |
Active, not recruiting |
National Cancer Institute (NCI) |
2013-02-15 |
| NCT03543969 |
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma |
https://ClinicalTrials.gov/show/NCT03543969 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2021-09-30 |
| NCT03425461 |
Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma |
https://ClinicalTrials.gov/show/NCT03425461 |
Active, not recruiting |
University of Utah |
2020-12-01 |
| NCT03396952 |
Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma |
https://ClinicalTrials.gov/show/NCT03396952 |
Recruiting |
University of California, San Francisco |
2022-06-07 |
| NCT04273061 |
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity |
https://ClinicalTrials.gov/show/NCT04273061 |
Recruiting |
British Columbia Cancer Agency |
2024-10-31 |
| NCT03329846 |
An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT03329846 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-07-31 |
| NCT03325101 |
Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery |
https://ClinicalTrials.gov/show/NCT03325101 |
Recruiting |
Mayo Clinic |
2022-10-31 |
| NCT03315286 |
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure |
https://ClinicalTrials.gov/show/NCT03315286 |
Completed |
Weill Medical College of Cornell University |
2019-01-31 |
| NCT03313492 |
Modifying Young Adult Skin Cancer Risk and Protective Behaviors |
https://ClinicalTrials.gov/show/NCT03313492 |
Active, not recruiting |
Rutgers, The State University of New Jersey |
2019-07-31 |
| NCT03291002 |
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC |
https://ClinicalTrials.gov/show/NCT03291002 |
Recruiting |
CureVac AG |
2022-10-31 |
| NCT03281161 |
Sun Safe Workplaces: Assessment of Benefits and Costs of a Policy Intervention |
https://ClinicalTrials.gov/show/NCT03281161 |
Completed |
Klein Buendel, Inc. |
2017-04-30 |
| NCT03278340 |
Using Technology to Scale-Up an Occupational Sun Protection Policy Program |
https://ClinicalTrials.gov/show/NCT03278340 |
Enrolling by invitation |
Klein Buendel, Inc. |
2022-06-30 |
| NCT03276832 |
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma |
https://ClinicalTrials.gov/show/NCT03276832 |
Recruiting |
Mayo Clinic |
2021-02-15 |
| NCT03246412 |
Nevus Doctor Clinical Decision Support for GPs |
https://ClinicalTrials.gov/show/NCT03246412 |
Recruiting |
University Hospital of North Norway |
2020-12-31 |
| NCT03243929 |
Translation of District Sun Safe Policies to Schools |
https://ClinicalTrials.gov/show/NCT03243929 |
Completed |
Claremont Graduate University |
2018-03-21 |
| NCT03237013 |
Strategies to Promote Skin Health |
https://ClinicalTrials.gov/show/NCT03237013 |
Completed |
San Diego State University |
2016-12-14 |
| NCT03229278 |
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma |
https://ClinicalTrials.gov/show/NCT03229278 |
Active, not recruiting |
Rutgers, The State University of New Jersey |
2022-07-30 |
| NCT03201120 |
Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing |
https://ClinicalTrials.gov/show/NCT03201120 |
Completed |
University of Pennsylvania |
2017-09-28 |
| NCT03199911 |
Topical Antibiotic Prophylaxis for Eyelids |
https://ClinicalTrials.gov/show/NCT03199911 |
Recruiting |
University of California, San Francisco |
2020-04-30 |
| NCT03175432 |
Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases |
https://ClinicalTrials.gov/show/NCT03175432 |
Recruiting |
M.D. Anderson Cancer Center |
2021-06-30 |
| NCT03154190 |
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT03154190 |
Recruiting |
Stanford University |
2020-11-30 |
| NCT03132012 |
Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection |
https://ClinicalTrials.gov/show/NCT03132012 |
Completed |
Yale University |
2018-02-27 |
| NCT03131908 |
Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss |
https://ClinicalTrials.gov/show/NCT03131908 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT03131713 |
Preoperative Acetaminophen and Carbohydrate Loading |
https://ClinicalTrials.gov/show/NCT03131713 |
Completed |
Tufts Medical Center |
2017-12-31 |
| NCT03112668 |
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners |
https://ClinicalTrials.gov/show/NCT03112668 |
Completed |
Rutgers, The State University of New Jersey |
2018-01-25 |
| NCT03101358 |
Study of Topical SOR007 Ointment for Cutaneous Metastases |
https://ClinicalTrials.gov/show/NCT03101358 |
Active, not recruiting |
NanOlogy, LLC |
2020-05-31 |
| NCT03093909 |
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases |
https://ClinicalTrials.gov/show/NCT03093909 |
Recruiting |
M.D. Anderson Cancer Center |
2021-11-30 |
| NCT03079232 |
Optical Coherence Microscopy in Dermato-oncology |
https://ClinicalTrials.gov/show/NCT03079232 |
Completed |
Centre Hospitalier Universitaire de Saint Etienne |
2018-08-01 |
| NCT03071406 |
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03071406 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2023-07-31 |
| NCT03057327 |
Promoting Early Detection of Melanoma During the Mammography Experience |
https://ClinicalTrials.gov/show/NCT03057327 |
Completed |
Northwestern University |
2017-07-27 |
| NCT03025256 |
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease |
https://ClinicalTrials.gov/show/NCT03025256 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-30 |
| NCT03021460 |
Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT03021460 |
Recruiting |
Mayo Clinic |
2021-02-01 |
| NCT03012581 |
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types |
https://ClinicalTrials.gov/show/NCT03012581 |
Recruiting |
UNICANCER |
2023-01-31 |
| NCT03012009 |
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT03012009 |
Completed |
University Hospital, Ghent |
2017-05-31 |
| NCT02978625 |
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers |
https://ClinicalTrials.gov/show/NCT02978625 |
Recruiting |
National Cancer Institute (NCI) |
2021-06-01 |
| NCT02971709 |
Use of Shade in U.S. and Australian City Parks |
https://ClinicalTrials.gov/show/NCT02971709 |
Completed |
Klein Buendel, Inc. |
2017-05-31 |
| NCT02941744 |
A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases |
https://ClinicalTrials.gov/show/NCT02941744 |
Completed |
Universitair Ziekenhuis Brussel |
2018-12-31 |
| NCT02902822 |
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo |
https://ClinicalTrials.gov/show/NCT02902822 |
Completed |
Centro Studi Gised |
2019-05-31 |
| NCT02897765 |
A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer |
https://ClinicalTrials.gov/show/NCT02897765 |
Completed |
Neon Therapeutics, Inc. |
2020-02-29 |
| NCT02872909 |
Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer |
https://ClinicalTrials.gov/show/NCT02872909 |
Completed |
University of Dundee |
2017-02-06 |
| NCT02857374 |
Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy |
https://ClinicalTrials.gov/show/NCT02857374 |
Completed |
Roswell Park Cancer Institute |
2018-08-28 |
| NCT02836548 |
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT02836548 |
Recruiting |
The Netherlands Cancer Institute |
2019-06-30 |
| NCT02835807 |
Engaging Moms on Teen Indoor Tanning Through Social Media |
https://ClinicalTrials.gov/show/NCT02835807 |
Recruiting |
Klein Buendel, Inc. |
2021-01-31 |
| NCT02824289 |
Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers |
https://ClinicalTrials.gov/show/NCT02824289 |
Completed |
Klein Buendel, Inc. |
2015-04-30 |
| NCT02816021 |
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT02816021 |
Recruiting |
M.D. Anderson Cancer Center |
2025-02-28 |
| NCT02780934 |
Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction |
https://ClinicalTrials.gov/show/NCT02780934 |
Completed |
Dartmouth-Hitchcock Medical Center |
2016-05-31 |
| NCT02760160 |
Dietary Prevention of Photodamage in Skin With Grapes |
https://ClinicalTrials.gov/show/NCT02760160 |
Completed |
University of Alabama at Birmingham |
2018-09-27 |
| NCT02751151 |
Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients |
https://ClinicalTrials.gov/show/NCT02751151 |
Recruiting |
Inova Health Care Services |
2020-02-29 |
| NCT02748564 |
Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma |
https://ClinicalTrials.gov/show/NCT02748564 |
Active, not recruiting |
Rutgers, The State University of New Jersey |
2021-06-30 |
| NCT02721459 |
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma |
https://ClinicalTrials.gov/show/NCT02721459 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2019-10-31 |
| NCT02705352 |
5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts |
https://ClinicalTrials.gov/show/NCT02705352 |
Completed |
Massachusetts Eye and Ear Infirmary |
2019-01-25 |
| NCT02704104 |
Safety and Performance Evaluation of the Topical Hemostatic Device (AC5â„¢) Following Excision of Skin Lesions |
https://ClinicalTrials.gov/show/NCT02704104 |
Completed |
ARCH Therapuetics |
2016-06-30 |
| NCT02668614 |
Early Detection of Skin Cancer With Sensor Technology |
https://ClinicalTrials.gov/show/NCT02668614 |
Completed |
Lawson Health Research Institute |
2018-02-28 |
| NCT02652455 |
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT02652455 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-08-30 |
| NCT02636569 |
Topical Chemoprevention of Skin Cancer Biomarkers |
https://ClinicalTrials.gov/show/NCT02636569 |
Recruiting |
University of Alabama at Birmingham |
2021-03-31 |
| NCT03033576 |
Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT03033576 |
Recruiting |
National Cancer Institute (NCI) |
2022-03-15 |
| NCT02650986 |
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 |
https://ClinicalTrials.gov/show/NCT02650986 |
Recruiting |
Roswell Park Cancer Institute |
2021-06-20 |
| NCT02224781 |
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma |
https://ClinicalTrials.gov/show/NCT02224781 |
Recruiting |
National Cancer Institute (NCI) |
2022-10-02 |
| NCT01940809 |
Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01940809 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT03028948 |
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma |
https://ClinicalTrials.gov/show/NCT03028948 |
Active, not recruiting |
Rutgers, The State University of New Jersey |
2021-01-31 |
| NCT02910700 |
Nivolumab and Trametinib With or Without Dabrafenib in Treating Patients With BRAF Mutated or Wild Type Metastatic Stage III-IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02910700 |
Recruiting |
M.D. Anderson Cancer Center |
2021-12-31 |
| NCT02595866 |
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms |
https://ClinicalTrials.gov/show/NCT02595866 |
Recruiting |
National Cancer Institute (NCI) |
2021-07-01 |
| NCT02465060 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT02465060 |
Recruiting |
National Cancer Institute (NCI) |
2022-06-30 |
| NCT01989572 |
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01989572 |
Completed |
National Cancer Institute (NCI) |
2012-10-08 |
| NCT01950390 |
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01950390 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-07-01 |
| NCT01480154 |
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT01480154 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-02-14 |
| NCT02550678 |
A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02550678 |
Completed |
Ascend Biopharmaceuticals Ltd |
2017-11-30 |
| NCT02519322 |
Neoadjuvant and Adjuvant Checkpoint Blockade |
https://ClinicalTrials.gov/show/NCT02519322 |
Recruiting |
M.D. Anderson Cancer Center |
2020-08-01 |
| NCT02500576 |
Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT02500576 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-08-31 |
| NCT02423863 |
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® |
https://ClinicalTrials.gov/show/NCT02423863 |
Recruiting |
Oncovir, Inc. |
2021-06-30 |
| NCT02409628 |
EktoTherixâ„¢ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds |
https://ClinicalTrials.gov/show/NCT02409628 |
Completed |
Neotherix Limited |
2017-07-31 |
| NCT02385214 |
MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT02385214 |
Active, not recruiting |
Melanoma and Skin Cancer Trials Limited |
2026-08-05 |
| NCT02373722 |
Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery |
https://ClinicalTrials.gov/show/NCT02373722 |
Completed |
Wake Forest University Health Sciences |
2016-03-31 |
| NCT02352428 |
Skin Cancer Screening Education Study |
https://ClinicalTrials.gov/show/NCT02352428 |
Active, not recruiting |
Association of Dermatological Prevention, Germany |
2018-12-31 |
| NCT02324608 |
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer |
https://ClinicalTrials.gov/show/NCT02324608 |
Recruiting |
Rutgers, The State University of New Jersey |
2020-11-30 |
| NCT02320305 |
MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02320305 |
Completed |
Mayo Clinic |
2015-12-07 |
| NCT02304458 |
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas |
https://ClinicalTrials.gov/show/NCT02304458 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-01-31 |
| NCT02298959 |
Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02298959 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT02248584 |
VITAMIN E, C and ZINC IN PATIENTS WITH SKIN CANCER: INFLUENCE ON OXIDATIVE STRESS AND INFLAMMATORY STATE |
https://ClinicalTrials.gov/show/NCT02248584 |
Completed |
University of Campinas, Brazil |
2011-12-31 |
| NCT02231775 |
Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation |
https://ClinicalTrials.gov/show/NCT02231775 |
Recruiting |
M.D. Anderson Cancer Center |
2022-10-31 |
| NCT02196181 |
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02196181 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT02192918 |
Pilot Investigation of Behavioral Alternatives to Indoor Tanning |
https://ClinicalTrials.gov/show/NCT02192918 |
Completed |
University of Massachusetts, Worcester |
2015-04-30 |
| NCT02166996 |
A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck |
https://ClinicalTrials.gov/show/NCT02166996 |
Completed |
Sundsvall Hospital |
2013-01-31 |
| NCT02147080 |
A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults |
https://ClinicalTrials.gov/show/NCT02147080 |
Completed |
Fox Chase Cancer Center |
2014-10-31 |
| NCT03384836 |
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT03384836 |
Recruiting |
Roswell Park Cancer Institute |
2020-10-11 |
| NCT02130297 |
Post Excision/Mohs Scar Laser Resurfacing |
https://ClinicalTrials.gov/show/NCT02130297 |
Completed |
Icahn School of Medicine at Mount Sinai |
2019-03-19 |
| NCT02129075 |
CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV Melanoma |
https://ClinicalTrials.gov/show/NCT02129075 |
Active, not recruiting |
National Cancer Institute (NCI) |
2016-03-28 |
| NCT02125058 |
Intracutaneous Versus Transcutaneous Sutures in the Face (IC vs TC Sutures) |
https://ClinicalTrials.gov/show/NCT02125058 |
Completed |
Maastricht University Medical Center |
2016-04-30 |
| NCT02097875 |
Safety Study of a Fluorescent Marker to Visualize Cancer Cells |
https://ClinicalTrials.gov/show/NCT02097875 |
Completed |
Blaze Bioscience Australia Pty Ltd |
2015-03-31 |
| NCT02097225 |
Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02097225 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-03-31 |
| NCT01303341 |
Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma |
https://ClinicalTrials.gov/show/NCT01303341 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-04-16 |
| NCT01292668 |
Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer |
https://ClinicalTrials.gov/show/NCT01292668 |
Completed |
Roswell Park Cancer Institute |
2012-07-31 |
| NCT01274338 |
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01274338 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-02-15 |
| NCT02046811 |
Reducing Skin Cancer Risk in Childhood Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02046811 |
Completed |
Harvard School of Public Health |
2018-01-01 |
| NCT02036476 |
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02036476 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2020-12-31 |
| NCT02032810 |
Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma |
https://ClinicalTrials.gov/show/NCT02032810 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2017-09-06 |
| NCT02965716 |
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma |
https://ClinicalTrials.gov/show/NCT02965716 |
Recruiting |
National Cancer Institute (NCI) |
2020-06-30 |
| NCT01989559 |
Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01989559 |
Completed |
National Cancer Institute (NCI) |
2013-09-30 |
| NCT01973322 |
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized “Proof-of-principle” Phase II Study |
https://ClinicalTrials.gov/show/NCT01973322 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2020-08-31 |
| NCT01961115 |
Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma |
https://ClinicalTrials.gov/show/NCT01961115 |
Completed |
Fred Hutchinson Cancer Research Center |
2016-10-31 |
| NCT01955460 |
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma |
https://ClinicalTrials.gov/show/NCT01955460 |
Recruiting |
M.D. Anderson Cancer Center |
2020-10-31 |
| NCT01941901 |
Calcium Electroporation for Treatment of Cutaneous Metastases |
https://ClinicalTrials.gov/show/NCT01941901 |
Completed |
Herlev Hospital |
2016-09-30 |
| NCT01886235 |
Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01886235 |
Active, not recruiting |
Roswell Park Cancer Institute |
2015-06-16 |
| NCT01861496 |
Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours |
https://ClinicalTrials.gov/show/NCT01861496 |
Recruiting |
Oncology Venture |
2020-09-30 |
| NCT01835626 |
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01835626 |
Completed |
University of California, San Francisco |
2019-09-10 |
| NCT01820234 |
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event |
https://ClinicalTrials.gov/show/NCT01820234 |
Completed |
University of California, Davis |
2011-06-30 |
| NCT01807182 |
Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT01807182 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2020-06-30 |
| NCT01804595 |
A Randomized Control Trial of Sun Protection Interventions for Operating Engineers |
https://ClinicalTrials.gov/show/NCT01804595 |
Completed |
University of Michigan |
2013-12-31 |
| NCT01791894 |
Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01791894 |
Completed |
Stanford University |
2013-11-30 |
| NCT04204837 |
Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin |
https://ClinicalTrials.gov/show/NCT04204837 |
Recruiting |
Salzburger Landeskliniken |
2021-03-31 |
| NCT01748448 |
Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome |
https://ClinicalTrials.gov/show/NCT01748448 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2023-09-30 |
| NCT01740557 |
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT01740557 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-01-31 |
| NCT01738139 |
Ipilimumab and Imatinib Mesylate in Advanced Cancer |
https://ClinicalTrials.gov/show/NCT01738139 |
Recruiting |
M.D. Anderson Cancer Center |
2022-02-28 |
| NCT01727076 |
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01727076 |
Completed |
National Cancer Institute (NCI) |
2016-06-30 |
| NCT01708941 |
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01708941 |
Active, not recruiting |
National Cancer Institute (NCI) |
2017-08-08 |
| NCT01693068 |
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT01693068 |
Completed |
EMD Serono |
2015-07-04 |
| NCT01644591 |
Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases |
https://ClinicalTrials.gov/show/NCT01644591 |
Recruiting |
M.D. Anderson Cancer Center |
2020-08-31 |
| NCT01638533 |
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT01638533 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-11-29 |
| NCT01526486 |
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer |
https://ClinicalTrials.gov/show/NCT01526486 |
Completed |
Emory University |
2013-02-28 |
| NCT01522820 |
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors |
https://ClinicalTrials.gov/show/NCT01522820 |
Completed |
Roswell Park Cancer Institute |
2016-07-31 |
| NCT01508013 |
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk |
https://ClinicalTrials.gov/show/NCT01508013 |
Completed |
East Tennessee State University |
2014-05-31 |
| NCT01482104 |
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT01482104 |
Completed |
Norwegian University of Science and Technology |
2017-10-31 |
| NCT01464957 |
Skin Cancer Prevention in a Pediatric Population |
https://ClinicalTrials.gov/show/NCT01464957 |
Completed |
University of Colorado, Denver |
2007-09-30 |
| NCT01463709 |
Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer |
https://ClinicalTrials.gov/show/NCT01463709 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2012-06-30 |
| NCT01460875 |
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma |
https://ClinicalTrials.gov/show/NCT01460875 |
Completed |
Ohio State University Comprehensive Cancer Center |
2014-01-05 |
| NCT01458002 |
Online Tailored Interventions & Relational Agents for Exercise and Sun Protection |
https://ClinicalTrials.gov/show/NCT01458002 |
Completed |
University of Rhode Island |
2013-05-31 |
| NCT01447355 |
Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation |
https://ClinicalTrials.gov/show/NCT01447355 |
Completed |
National Cancer Institute (NCI) |
2012-10-31 |
| NCT01359735 |
Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients |
https://ClinicalTrials.gov/show/NCT01359735 |
Completed |
Healthpoint |
2011-11-30 |
| NCT01356771 |
Melanoma Risk Assessment & Tailored Intervention |
https://ClinicalTrials.gov/show/NCT01356771 |
Completed |
University of Pennsylvania |
2016-02-29 |
| NCT01319565 |
Prospective Randomized Study of Cell Therapy for Metastatic Melanoma Using Short-Term Cultured Tumor Infiltrating Lymphocytes Plus IL-2 Following Either a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Alone or in Conjunction w/1200 TBI |
https://ClinicalTrials.gov/show/NCT01319565 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2024-06-01 |
| NCT01989585 |
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01989585 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT04377360 |
Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors |
https://ClinicalTrials.gov/show/NCT04377360 |
Recruiting |
Alpha Tau Medical LTD. |
2021-06-30 |
| NCT04341064 |
Sun-safe Habits Intervention and Education |
https://ClinicalTrials.gov/show/NCT04341064 |
Recruiting |
University of Utah |
2025-02-28 |
| NCT04310397 |
Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma |
https://ClinicalTrials.gov/show/NCT04310397 |
Recruiting |
M.D. Anderson Cancer Center |
2022-02-28 |
| NCT04251598 |
I am Protecting my Child From the Sun Program |
https://ClinicalTrials.gov/show/NCT04251598 |
Completed |
Akdeniz University |
2018-06-15 |
| NCT04176237 |
School-based Randomized Trial of SunSmart Interventions |
https://ClinicalTrials.gov/show/NCT04176237 |
Completed |
University of Southern California |
2017-01-10 |
| NCT04163419 |
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis |
https://ClinicalTrials.gov/show/NCT04163419 |
Active, not recruiting |
Massachusetts General Hospital |
2023-06-30 |
| NCT04138342 |
Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer |
https://ClinicalTrials.gov/show/NCT04138342 |
Recruiting |
Al-Azhar University |
2021-06-14 |
| NCT04112342 |
Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry |
https://ClinicalTrials.gov/show/NCT04112342 |
Enrolling by invitation |
West Virginia University |
2020-05-21 |
| NCT04059588 |
A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin |
https://ClinicalTrials.gov/show/NCT04059588 |
Recruiting |
Rockefeller University |
2021-07-31 |
| NCT04056962 |
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma |
https://ClinicalTrials.gov/show/NCT04056962 |
Recruiting |
West China Hospital |
2021-08-30 |
| NCT04040114 |
Improving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI) |
https://ClinicalTrials.gov/show/NCT04040114 |
Recruiting |
Melanoma and Skin Cancer Trials Limited |
2020-10-31 |
| NCT04036344 |
Buddy Relationships in DermatoloGic Excisions for Skin Cancer |
https://ClinicalTrials.gov/show/NCT04036344 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2019-08-27 |
| NCT04007744 |
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT04007744 |
Recruiting |
Mayo Clinic |
2021-07-31 |
| NCT03979872 |
Risk Information and Skin-cancer Education for Undergraduate Prevention |
https://ClinicalTrials.gov/show/NCT03979872 |
Enrolling by invitation |
University of Utah |
2021-05-15 |
| NCT03944941 |
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer |
https://ClinicalTrials.gov/show/NCT03944941 |
Recruiting |
Alliance for Clinical Trials in Oncology |
2022-12-31 |
| NCT03906253 |
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia |
https://ClinicalTrials.gov/show/NCT03906253 |
Recruiting |
Wright State Physicians |
2025-12-31 |
| NCT03901573 |
High-Risk Skin Cancers With Atezolizumab Plus NT-I7 |
https://ClinicalTrials.gov/show/NCT03901573 |
Recruiting |
NeoImmuneTech |
2024-02-29 |
| NCT03873818 |
Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain |
https://ClinicalTrials.gov/show/NCT03873818 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-05-01 |
| NCT03865212 |
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma |
https://ClinicalTrials.gov/show/NCT03865212 |
Recruiting |
Mayo Clinic |
2021-03-15 |
| NCT03860883 |
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT03860883 |
Recruiting |
Melanoma and Skin Cancer Trials Limited |
2029-12-31 |
| NCT03858855 |
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment |
https://ClinicalTrials.gov/show/NCT03858855 |
Completed |
Ohio State University Comprehensive Cancer Center |
2020-04-13 |
| NCT03816332 |
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers |
https://ClinicalTrials.gov/show/NCT03816332 |
Recruiting |
National Cancer Institute (NCI) |
2021-05-30 |
| NCT03769285 |
Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial |
https://ClinicalTrials.gov/show/NCT03769285 |
Recruiting |
Women’s College Hospital |
2020-12-31 |
| NCT03769155 |
VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma |
https://ClinicalTrials.gov/show/NCT03769155 |
Recruiting |
Emory University |
2021-12-31 |
| NCT03767660 |
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation |
https://ClinicalTrials.gov/show/NCT03767660 |
Recruiting |
Peking Union Medical College Hospital |
2022-01-01 |
| NCT03767348 |
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab |
https://ClinicalTrials.gov/show/NCT03767348 |
Recruiting |
Replimune Inc. |
2021-11-30 |
| NCT03754140 |
Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases |
https://ClinicalTrials.gov/show/NCT03754140 |
Recruiting |
Melanoma Institute Australia |
2021-05-31 |
| NCT03752736 |
Sun Safety Skills for Elementary School Students |
https://ClinicalTrials.gov/show/NCT03752736 |
Completed |
Stanford University |
2019-04-11 |
| NCT03740815 |
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection |
https://ClinicalTrials.gov/show/NCT03740815 |
Recruiting |
Instituto Nacional de Cancer, Brazil |
2019-07-31 |
| NCT03737734 |
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) |
https://ClinicalTrials.gov/show/NCT03737734 |
Recruiting |
Alpha Tau Medical LTD. |
2020-12-31 |
| NCT03731247 |
Optical Coherence Microscopy in Dermato-oncology |
https://ClinicalTrials.gov/show/NCT03731247 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2020-09-30 |
| NCT03727789 |
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma |
https://ClinicalTrials.gov/show/NCT03727789 |
Recruiting |
Roswell Park Cancer Institute |
2021-08-08 |
| NCT03716193 |
Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry |
https://ClinicalTrials.gov/show/NCT03716193 |
Recruiting |
West Virginia University |
2020-06-01 |
| NCT03714828 |
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer |
https://ClinicalTrials.gov/show/NCT03714828 |
Recruiting |
University of Arizona |
2021-03-01 |
| NCT03677739 |
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families |
https://ClinicalTrials.gov/show/NCT03677739 |
Recruiting |
Rutgers, The State University of New Jersey |
2023-06-01 |
| NCT03673917 |
Cosmetology Students and Skin Cancer |
https://ClinicalTrials.gov/show/NCT03673917 |
Completed |
University of Arkansas |
2017-06-30 |
| NCT03655756 |
pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT03655756 |
Recruiting |
Morphogenesis, Inc. |
2020-08-31 |
| NCT03607578 |
Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations |
https://ClinicalTrials.gov/show/NCT03607578 |
Completed |
Danish Cancer Society |
2019-01-11 |
| NCT03590054 |
A Phase 1b Dose Escalation/Expansion Study of Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies |
https://ClinicalTrials.gov/show/NCT03590054 |
Recruiting |
University of California, San Francisco |
2022-02-15 |
| NCT03564769 |
Evaluation Study of SPOTme® Skin Cancer Screenings |
https://ClinicalTrials.gov/show/NCT03564769 |
Completed |
Harvard School of Public Health |
2018-10-01 |
| NCT03554083 |
Neoadjuvant Combination Targeted and Immunotherapy for Patients With High-Risk Stage III Melanoma |
https://ClinicalTrials.gov/show/NCT03554083 |
Recruiting |
Mayo Clinic |
2023-06-29 |
| NCT03541148 |
Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT03541148 |
Completed |
Catalysis SL |
2016-04-13 |
| NCT03534947 |
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03534947 |
Recruiting |
Melanoma Institute Australia |
2020-12-31 |
| NCT03458117 |
T-VEC in Non-melanoma Skin Cancer |
https://ClinicalTrials.gov/show/NCT03458117 |
Recruiting |
University of Zurich |
2020-02-29 |
| NCT03430934 |
Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor |
https://ClinicalTrials.gov/show/NCT03430934 |
Recruiting |
University of Missouri-Columbia |
2020-12-01 |
| NCT03420963 |
Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid Tumors |
https://ClinicalTrials.gov/show/NCT03420963 |
Recruiting |
M.D. Anderson Cancer Center |
2022-12-01 |
| NCT03419637 |
Mobile Devices as Educational Skin History Tools |
https://ClinicalTrials.gov/show/NCT03419637 |
Completed |
University of Pennsylvania |
2017-08-02 |
| NCT01258855 |
Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01258855 |
Completed |
National Cancer Institute (NCI) |
2018-03-29 |
| NCT01155258 |
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT01155258 |
Completed |
University of Southern California |
2013-01-31 |
| NCT01131234 |
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT01131234 |
Completed |
National Cancer Institute (NCI) |
2014-09-30 |
| NCT01118091 |
Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M… |
https://ClinicalTrials.gov/show/NCT01118091 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-04-30 |
| NCT01108094 |
Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT01108094 |
Completed |
Stanford University |
2011-03-31 |
| NCT01053819 |
Can We Miss Pigmented Lesions in Psoriasis Patients? |
https://ClinicalTrials.gov/show/NCT01053819 |
Completed |
University of Alabama at Birmingham |
2012-04-30 |
| NCT01032343 |
An Immunonutritional Approach to the Prevention of Skin Cancer |
https://ClinicalTrials.gov/show/NCT01032343 |
Completed |
University of Manchester |
2010-07-31 |
| NCT01032031 |
The Effect of Green Tea and Vitamin C on Skin Health |
https://ClinicalTrials.gov/show/NCT01032031 |
Completed |
University of Manchester |
2012-08-31 |
| NCT00993512 |
Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer |
https://ClinicalTrials.gov/show/NCT00993512 |
Completed |
PCI Biotech AS |
2011-05-31 |
| NCT00923195 |
Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00923195 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-08-31 |
| NCT00894855 |
Skin Cancer Screening and Education at Beaches |
https://ClinicalTrials.gov/show/NCT00894855 |
Completed |
Dana-Farber Cancer Institute |
2008-11-30 |
| NCT00885534 |
Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00885534 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-10-31 |
| NCT00866177 |
MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma |
https://ClinicalTrials.gov/show/NCT00866177 |
Completed |
National Cancer Institute (NCI) |
2013-09-30 |
| NCT00862901 |
Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma |
https://ClinicalTrials.gov/show/NCT00862901 |
Completed |
Tufts Medical Center |
2011-01-31 |
| NCT00859768 |
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients |
https://ClinicalTrials.gov/show/NCT00859768 |
Completed |
Netherlands Open University |
2010-10-31 |
| NCT00847912 |
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial |
https://ClinicalTrials.gov/show/NCT00847912 |
Completed |
VA Office of Research and Development |
2013-06-28 |
| NCT03719131 |
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy |
https://ClinicalTrials.gov/show/NCT03719131 |
Recruiting |
Emory University |
2021-10-31 |
| NCT00826306 |
Comparison Of Video-based Versus Written Patient Education on Sunscreen |
https://ClinicalTrials.gov/show/NCT00826306 |
Completed |
University of California, Davis |
2009-08-31 |
| NCT04127318 |
Low-moderate Intensity Pedaling During Immunotherapy Administration |
https://ClinicalTrials.gov/show/NCT04127318 |
Enrolling by invitation |
Rush University Medical Center |
2020-10-31 |
| NCT03509467 |
Using MC1R Genotype to Impact Melanoma Risk Behavior |
https://ClinicalTrials.gov/show/NCT03509467 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-11-30 |
| NCT03245788 |
Effectiveness of Lay Navigators in Meeting Cancer Patients’ Non-Clinical Needs: A Pilot Study |
https://ClinicalTrials.gov/show/NCT03245788 |
Completed |
Stanford University |
2018-07-31 |
| NCT01631331 |
Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT01631331 |
Completed |
Stanford University |
2015-09-17 |
| NCT00804908 |
A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00804908 |
Completed |
AbbVie |
2016-01-31 |
| NCT01130519 |
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT01130519 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-01 |
| NCT03096548 |
Sun Safety Ink! A Sun Safety Program for the Tattoo Community |
https://ClinicalTrials.gov/show/NCT03096548 |
Recruiting |
Klein Buendel, Inc. |
2021-01-01 |
| NCT02580916 |
Utility of the Skin Cancer Quality of Life Impact Tool |
https://ClinicalTrials.gov/show/NCT02580916 |
Completed |
Oxford University Hospitals NHS Trust |
2017-08-31 |
| NCT02581930 |
Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT02581930 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-02-10 |
| NCT03698019 |
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma |
https://ClinicalTrials.gov/show/NCT03698019 |
Recruiting |
National Cancer Institute (NCI) |
2022-09-01 |
| NCT02506153 |
High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02506153 |
Active, not recruiting |
National Cancer Institute (NCI) |
2023-09-15 |
| NCT00785369 |
In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis |
https://ClinicalTrials.gov/show/NCT00785369 |
Completed |
Lucid, Inc. |
2009-12-31 |
| NCT00784108 |
Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry. |
https://ClinicalTrials.gov/show/NCT00784108 |
Completed |
University of California, Irvine |
2012-09-30 |
| NCT00765193 |
The Impact of Total Body Skin Examination on Skin Cancer Detection |
https://ClinicalTrials.gov/show/NCT00765193 |
Completed |
Medical University of Graz |
2009-05-31 |
| NCT00709306 |
The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention |
https://ClinicalTrials.gov/show/NCT00709306 |
Completed |
Fox Chase Cancer Center |
2008-06-30 |
| NCT00705887 |
A Motivational Enhancement Approach to Skin Cancer Prevention |
https://ClinicalTrials.gov/show/NCT00705887 |
Completed |
Oregon Health and Science University |
2007-06-30 |
| NCT00665470 |
Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma |
https://ClinicalTrials.gov/show/NCT00665470 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-04-30 |
| NCT00655655 |
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00655655 |
Completed |
Mayo Clinic |
2009-09-15 |
| NCT00644384 |
Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer |
https://ClinicalTrials.gov/show/NCT00644384 |
Completed |
Mayo Clinic |
2006-05-31 |
| NCT00601640 |
Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin |
https://ClinicalTrials.gov/show/NCT00601640 |
Completed |
University of Arizona |
2010-02-28 |
| NCT00588341 |
Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection |
https://ClinicalTrials.gov/show/NCT00588341 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-03-31 |
| NCT00578214 |
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery |
https://ClinicalTrials.gov/show/NCT00578214 |
Completed |
Mayo Clinic |
2008-04-30 |
| NCT00563290 |
Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00563290 |
Completed |
National Cancer Institute (NCI) |
2012-04-30 |
| NCT00535769 |
Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use |
https://ClinicalTrials.gov/show/NCT00535769 |
Completed |
Massachusetts General Hospital |
2007-11-30 |
| NCT00520299 |
Study of ADI-PEG 20 in Patients With Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT00520299 |
Completed |
Ludwig Institute for Cancer Research |
2010-03-31 |
| NCT00509288 |
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes |
https://ClinicalTrials.gov/show/NCT00509288 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-07-31 |
| NCT00492895 |
Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00492895 |
Completed |
University of Zurich |
2010-12-31 |
| NCT00472459 |
PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer |
https://ClinicalTrials.gov/show/NCT00472459 |
Completed |
Galderma |
NA |
| NCT00433485 |
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants |
https://ClinicalTrials.gov/show/NCT00433485 |
Completed |
Yale University |
2008-03-31 |
| NCT00432471 |
Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers |
https://ClinicalTrials.gov/show/NCT00432471 |
Completed |
M.D. Anderson Cancer Center |
2017-06-25 |
| NCT00403377 |
Investigation of a Behavioral Substitute for Sunbathing |
https://ClinicalTrials.gov/show/NCT00403377 |
Completed |
University of Massachusetts, Worcester |
2007-12-31 |
| NCT00397982 |
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT00397982 |
Completed |
National Cancer Institute (NCI) |
2013-07-31 |
| NCT00387751 |
Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT00387751 |
Completed |
National Cancer Institute (NCI) |
2009-09-30 |
| NCT00367042 |
Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks |
https://ClinicalTrials.gov/show/NCT00367042 |
Completed |
University of California, Davis |
2006-07-31 |
| NCT00346021 |
Sun Protection for Florida’s Children |
https://ClinicalTrials.gov/show/NCT00346021 |
Completed |
University of South Florida |
2011-08-31 |
| NCT00295958 |
LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00295958 |
Completed |
National Institutes of Health Clinical Center (CC) |
2006-06-30 |
| NCT00224744 |
Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage |
https://ClinicalTrials.gov/show/NCT00224744 |
Completed |
Institut Claudius Regaud |
2013-01-31 |
| NCT00204789 |
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00204789 |
Completed |
University of Wisconsin, Madison |
2007-12-31 |
| NCT00193895 |
Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00193895 |
Completed |
Trans-Tasman Radiation Oncology Group (TROG) |
2016-03-31 |
| NCT00189332 |
Use of 852A in Metastatic Cutaneous Melanoma. |
https://ClinicalTrials.gov/show/NCT00189332 |
Completed |
Pfizer |
2006-08-31 |
| NCT00133887 |
TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00133887 |
Completed |
Hospices Civils de Lyon |
2011-03-31 |
| NCT00129961 |
Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00129961 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2009-01-31 |
| NCT00126555 |
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer |
https://ClinicalTrials.gov/show/NCT00126555 |
Completed |
National Cancer Institute (NCI) |
2013-02-28 |
| NCT00110019 |
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00110019 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00103246 |
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen’s Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT00103246 |
Completed |
Case Comprehensive Cancer Center |
2008-12-31 |
| NCT00094107 |
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00094107 |
Completed |
Pfizer |
2008-04-30 |
| NCT00089180 |
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant |
https://ClinicalTrials.gov/show/NCT00089180 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00005884 |
Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer |
https://ClinicalTrials.gov/show/NCT00005884 |
Completed |
University of Wisconsin, Madison |
2000-12-31 |
| NCT00002506 |
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer |
https://ClinicalTrials.gov/show/NCT00002506 |
Completed |
Hoag Memorial Hospital Presbyterian |
1996-01-31 |
| NCT00003549 |
S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer |
https://ClinicalTrials.gov/show/NCT00003549 |
Completed |
Southwest Oncology Group |
2001-09-30 |
| NCT00083252 |
Study of Talabostat and Cisplatin in Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT00083252 |
Completed |
Point Therapeutics |
NA |
| NCT00083239 |
Study of Talabostat in Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT00083239 |
Completed |
Point Therapeutics |
NA |
| NCT00079300 |
Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer |
https://ClinicalTrials.gov/show/NCT00079300 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00079131 |
Oblimersen in Treating Patients With Merkel Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00079131 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00025012 |
Isotretinoin in Preventing Skin Cancer |
https://ClinicalTrials.gov/show/NCT00025012 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00021294 |
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00021294 |
Completed |
University of Arizona |
2002-06-30 |
| NCT00068783 |
S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer |
https://ClinicalTrials.gov/show/NCT00068783 |
Completed |
National Cancer Institute (NCI) |
2007-06-30 |
| NCT00066872 |
Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer |
https://ClinicalTrials.gov/show/NCT00066872 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006361 |
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00006361 |
Completed |
National Cancer Institute (NCI) |
2003-01-31 |
| NCT00054691 |
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin |
https://ClinicalTrials.gov/show/NCT00054691 |
Completed |
M.D. Anderson Cancer Center |
2012-10-31 |
| NCT00027586 |
Imatinib Mesylate in Treating Patients With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00027586 |
Completed |
M.D. Anderson Cancer Center |
2005-01-31 |
| NCT00023621 |
Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome |
https://ClinicalTrials.gov/show/NCT00023621 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00021125 |
Radiation Therapy in Treating Patients With Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00021125 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019682 |
Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00019682 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00017485 |
Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer |
https://ClinicalTrials.gov/show/NCT00017485 |
Completed |
Roswell Park Cancer Institute |
2006-12-31 |
| NCT00003611 |
Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation |
https://ClinicalTrials.gov/show/NCT00003611 |
Completed |
Alliance for Clinical Trials in Oncology |
2003-02-28 |
| NCT00002975 |
Photodynamic Therapy in Treating Patients With Skin Cancer |
https://ClinicalTrials.gov/show/NCT00002975 |
Completed |
Roswell Park Cancer Institute |
2009-04-30 |
| NCT00002963 |
Photodynamic Therapy in Treating Patients With Skin Cancer |
https://ClinicalTrials.gov/show/NCT00002963 |
Completed |
Roswell Park Cancer Institute |
2007-06-30 |
| NCT00002882 |
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma |
https://ClinicalTrials.gov/show/NCT00002882 |
Completed |
M.D. Anderson Cancer Center |
2003-08-31 |
| NCT00044356 |
Phase II Trial of Allovectin-7® for Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00044356 |
Completed |
Vical |
2004-08-31 |
| NCT00007631 |
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer |
https://ClinicalTrials.gov/show/NCT00007631 |
Completed |
VA Office of Research and Development |
2004-11-30 |